Dados B3 › ORVR3 × SBSP3
ORVR3 × SBSP3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | ORVR3 | SBSP3 | year |
|---|---|---|---|
| ROE | 5.4% | 0.0% | 2025 |
| ROIC | 9.3% | 14.4% | 2025 |
| ROA | 1.9% | 9.1% | 2025 |
| Gross margin | 46.2% | 37.0% | 2025 |
| EBIT margin | 29.5% | 33.1% | 2025 |
| Net margin | 7.0% | 22.2% | 2025 |
| Net debt/EBITDA | 2.47x | 1.88x | 2025 |
| Current ratio | 2.36x | 1.12x | 2025 |
| Revenue growth (1y) | 16.3% | 5.4% | 2025 |
| Revenue growth (5y CAGR) | 21.8% | 16.4%! | 2025 |
| Piotroski F-Score | 6/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | ORVR3 | SBSP3 | year |
|---|---|---|---|
| P/E | 109.34x | — | 2025 |
| P/B | 4.56x | 2.55x | 2025 |
| EV/EBITDA | 15.24x | 9.17x | 2025 |
| FCF yield | -5.9% | -5.0% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:39 UTC. If this does not match /saude, you are reading a cached copy.